{"id":7619,"date":"2025-06-25T18:00:21","date_gmt":"2025-06-25T15:00:21","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7619"},"modified":"2025-06-25T18:00:21","modified_gmt":"2025-06-25T15:00:21","slug":"summary-cardiology-guidelines-must-be-sex-specific-for-female-heart-patients","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/summary-cardiology-guidelines-must-be-sex-specific-for-female-heart-patients\/","title":{"rendered":"Summary: Cardiology Guidelines Must Be Sex-Specific for Female Heart Patients"},"content":{"rendered":"
Summary: Cardiology Guidelines Must Be Sex-Specific for Female Heart Patients<\/div>\n
<\/div>\n
Highlighted: June 17, 2025 \u2013 in an expert cardiology update<\/div>\n
Featuring insights from Dr. Janet Wei, Cedars-Sinai Heart Institute.<\/div>\n
<\/div>\n
1. Women\u2019s Heart Disease Requires Distinct Guidelines<\/div>\n
\u2022 Cardiovascular disease (CVD) remains the leading cause of death among women.<\/span><\/div>\n
\u2022 Current clinical guidelines are largely based on male data, overlooking sex-specific presentations and risk factors.<\/span><\/div>\n
\u2022 Dr. Janet Wei (Cedars-Sinai) urges separate, sex-specific guidelines to address women\u2019s unique cardiovascular needs.<\/span><\/div>\n
2. Unique Risk Factors and Disease Patterns in Women<\/div>\n
\u2022 Traditional risk factors don\u2019t fully account for female-specific enhancers such as:<\/span><\/div>\n
\u2022 Early menopause<\/span><\/div>\n
\u2022 Pregnancy-related complications (e.g., preeclampsia)<\/span><\/div>\n
\u2022 Premature menopause or adverse outcomes<\/span><\/div>\n
\u2022 Pregnancy acts as a natural cardiovascular stress test, unmasking latent heart conditions.<\/span><\/div>\n
3. Different Disease Mechanisms and Presentations<\/div>\n
\u2022 Women are more prone to:<\/span><\/div>\n
\u2022 MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries)<\/span><\/div>\n
\u2022 Microvascular dysfunction, vasospasm, and plaque erosion<\/span><\/div>\n
\u2022 Misdiagnosis is common due to atypical symptoms and absence of obstructive coronary lesions.<\/span><\/div>\n
4. Rising Mortality in Younger Women<\/div>\n
\u2022 Women typically present with CVD about 10 years later than men, partly due to estrogen\u2019s protective effects.<\/span><\/div>\n
\u2022 However, CVD mortality is rising again, especially in women under 55.<\/span><\/div>\n
\u2022 Highlights the need for early risk assessment, particularly in women with adverse reproductive histories.<\/span><\/div>\n
5. Differences in Treatment Response<\/div>\n
\u2022 Women have:<\/span><\/div>\n
\u2022 Higher bleeding risk post-MI or surgery<\/span><\/div>\n
\u2022 Better outcomes with less invasive procedures (e.g., radial access)<\/span><\/div>\n
\u2022 Sex-specific planning is needed for interventions like TAVR valve sizing and antithrombotic therapy.<\/span><\/div>\n
6. New Evidence with Emerging Therapies<\/div>\n
\u2022 Women respond more significantly to GLP-1 receptor agonists, with greater weight loss than men.<\/span><\/div>\n
\u2022 Ongoing research is exploring how these differences may affect cardiovascular outcomes.<\/span><\/div>\n
7. Call to Action: Sex-Specific Guidelines<\/div>\n
\u2022 Dr. Wei and other experts call on societies like ACC and AHA to:<\/span><\/div>\n
\u2022 Develop dedicated female cardiovascular guidelines<\/span><\/div>\n
\u2022 Incorporate hormonal stages (pre-, peri-, post-menopause) into treatment plans<\/span><\/div>\n
\u2022 The future of cardiology must embrace individualized, sex-based care models.<\/span><\/div>\n","protected":false},"excerpt":{"rendered":"

Summary: Cardiology Guidelines Must Be Sex-Specific for Female Heart Patients Highlighted: June 17, 2025 \u2013 in an expert cardiology update Featuring insights from Dr. Janet Wei, Cedars-Sinai Heart Institute. 1. Women\u2019s Heart Disease Requires Distinct Guidelines \u2022 Cardiovascular disease (CVD) remains the leading cause of death among women. \u2022 Current clinical guidelines are largely based […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7619","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7619"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7619\/revisions"}],"predecessor-version":[{"id":7627,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7619\/revisions\/7627"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}